Soleno Therapeutics(Slno) Financials: Total Asset Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - total asset turnover
This chart shows the historical trend of total asset turnover for SLNO compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Total Asset Turnover
Definition: Total asset turnover measures how efficiently the company generates sales from its entire asset base. A high turnover means the company gets a lot of sales out of relatively fewer assets — very efficient. A low turnover may suggest underused assets or bloated balance sheets.
Interpretation:
• In '2021', SLNO's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2021' stood at 0.59.
• In '2022', SLNO's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The figure remained stable compared to '2021'. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2022' stood at 0.54. Industry average declined by 0.05 from previous year.
• In '2023', SLNO's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The figure remained stable compared to '2022'. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2023' stood at 0.55. Industry average increased by 0.01 compared to previous year.
• In '2024', SLNO's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The figure remained stable compared to '2023'. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2024' stood at 0.53. Industry average declined by 0.02 from previous year.
Overall, SLNO's total asset turnover has remained generally stable over the past 4 years.
Formula: Total Asset Turnover = Net Sales / Total Assets
Good Range: Ranges from 0.5 to 2 depending on business type.